These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 10750760

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
    Ranze O, Ranze P, Magnani HN, Greinacher A.
    Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
    [Abstract] [Full Text] [Related]

  • 3. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K, Martens S, Strouhal U, Matheis G, Lindhoff-Last E, Wimmer-Greinecker G, Lischke V.
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [Abstract] [Full Text] [Related]

  • 4. Heparin-induced thrombocytopenia (HIT): in vitro and in vivo cross-reactivity to danaparoid sodium and successful treatment with recombinant hirudin (lepirudin).
    Baumgärtel MW, Eichler P, Glöckner WM, Ranze O, Greinacher A.
    Eur J Haematol; 2000 Aug; 65(2):148-9. PubMed ID: 10966178
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Heparin-induced thrombocytopenia-alternative anticoagulation in pregnancy and lactation.
    Lindhoff-Last E, Bauersachs R.
    Semin Thromb Hemost; 2002 Oct; 28(5):439-46. PubMed ID: 12420239
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heparin induced thrombocytopenia. Experiences in 12 heart surgery patients.
    Sodian R, Loebe M, Gorman KF, Riess H, Hetzer R.
    ASAIO J; 1997 Oct; 43(5):M430-3. PubMed ID: 9360077
    [Abstract] [Full Text] [Related]

  • 11. Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.
    Severin T, Zieger B, Sutor AH.
    Semin Thromb Hemost; 2002 Oct; 28(5):447-54. PubMed ID: 12420240
    [Abstract] [Full Text] [Related]

  • 12. New treatment options for heparin-induced thrombocytopenia.
    Ortel TL, Chong BH.
    Semin Hematol; 1998 Oct; 35(4 Suppl 5):26-34; discussion 35-6. PubMed ID: 9855181
    [Abstract] [Full Text] [Related]

  • 13. [Extracorporeal circulation with danaparoid sodium for valve replacement in thrombocytopenia induced by type II heparin].
    Salmi L, Leroy-Matheron C, LeBesnerais P, Rosanval O, Duvaldestin P, Gouault-Heilmann M.
    Ann Fr Anesth Reanim; 2001 Nov; 20(9):799-802. PubMed ID: 11759322
    [Abstract] [Full Text] [Related]

  • 14. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
    Saxon BR, Black MD, Edgell D, Noel D, Leaker MT.
    Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
    [Abstract] [Full Text] [Related]

  • 15. The management of heparin-induced thrombocytopenia.
    Keeling D, Davidson S, Watson H, Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology.
    Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
    [Abstract] [Full Text] [Related]

  • 16. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes.
    Rice L, Nguyen PH, Vann AR.
    Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI, Markham A.
    Drugs; 1997 Dec; 54(6):903-24. PubMed ID: 9421696
    [Abstract] [Full Text] [Related]

  • 19. Heparin-induced thrombocytopenia type II on hemodialysis: switch to danaparoid.
    Neuhaus TJ, Goetschel P, Schmugge M, Leumann E.
    Pediatr Nephrol; 2000 Aug; 14(8-9):713-6. PubMed ID: 10955913
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of danaparoid sodium (ORG 10172) in critically ill patients with heparin-associated thrombocytopenia.
    Tardy-Poncet B, Tardy B, Reynaud J, Mahul P, Mismetti P, Mazet E, Guyotat D.
    Chest; 1999 Jun; 115(6):1616-20. PubMed ID: 10378558
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.